Incidence and Risk Factors for Secondary Glaucoma in Eyes with Uveal Melanoma

被引:5
|
作者
Stadigh, Anni E. [1 ,2 ,4 ,5 ]
Puska, Paivi M. [1 ,2 ,3 ]
Kivela, Tero T. [2 ,3 ]
机构
[1] Univ Helsinki, Dept Ophthalmol, Glaucoma Serv, Helsinki, Finland
[2] Helsinki Univ Hosp, Helsinki, Finland
[3] Univ Helsinki, Dept Ophthalmol, Ocular Oncol Serv, Helsinki, Finland
[4] Univ Helsinki, Dept Ophthalmol, Haartmaninkatu 4 C PL 220, Helsinki 00029, Finland
[5] Helsinki Univ Hosp, Haartmaninkatu 4 C PL 220, Helsinki 00029, Finland
来源
OPHTHALMOLOGY GLAUCOMA | 2023年 / 6卷 / 01期
关键词
Brachytherapy; Neovascular glaucoma; Secondary glaucoma; Uveal melanoma; ANTERIOR-CHAMBER ANGLE; PLAQUE RADIOTHERAPY; IRIS MELANOMA; CILIARY BODY; IODINE BRACHYTHERAPY; OCULAR COMPLICATIONS; VISUAL OUTCOMES; TUMOR-CONTROL; JUXTAPAPILLARY; RU-106;
D O I
10.1016/j.ogla.2022.08.002
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To estimate incidence of and analyze risk factors for developing secondary glaucoma in eyes with uveal melanoma before and after diagnosis.Design: A cross-sectional, population-based cohort study.Participants: Seven hundred eighty-one patients (median age, 64 years; range, 14-93) consecutively diagnosed with uveal melanoma from 1997 to 2012 in a national ocular oncology service, 708 (91%) of whom received ruthenium (50%) or iodine (50%) brachytherapy.Methods: Patient, tumor, treatment, and follow-up data were collected prospectively. Frequency and associations of melanoma-related glaucoma at tumor diagnosis were assessed. Incidence of developing secondary glaucoma after diagnosis was estimated by Kaplan-Meier analysis. Independent risk factors were modeled using Cox regression.Main Outcome Measures: Melanoma-related glaucoma and related risk factors.Results: Forty-five patients (5.8%; 95% confidence interval [CI], 4.2-7.6) had tumor-related secondary glaucoma at diagnosis, 34 (76%) from a narrow-to-closed angle (25 had direct angle invasion) and 10 (22%) from anterior neovascularization. Synchronous metastases were common in patients with initial secondary glaucoma (11% vs. 1.2% with incident glaucoma, P = 0.005). Patients with secondary glaucoma were often male (58% vs. 48% without glaucoma; P = 0.010) and had larger tumors (median thickness, 9.1 vs. 4.0 mm; P < 0.001) involving the ciliary body (43% vs. 21%; P < 0.001) with retinal detachment (53% vs. 30%; P < 0.001). One hundred and sixty-eight patients 165 of which were treated with brachytherapy developed incident tumor-or treatment-related secondary glaucoma a median of 1.7 years (range, 0.1-13.6) after tumor diagnosis. Cumulative proportion of developing secondary glaucoma was 23% (95% CI, 20-27) at 5 years. The most common mechanism was neovascularization in 119 patients (71%; 95% CI, 63-78). By multivariable regression, initial retinal detachment 3 to 4 quadrants (hazard ratio [HR], 2.18; P < 0.001), initial intraocular pressure 17 mmHg or higher (HR, 1.64; P = 0.01), and tumor thickness predicted incident secondary glaucoma.Conclusions: Secondary glaucoma at initial uveal melanoma diagnosis predicts high risk of synchronous metastases. Although anterior neovascularization is the most common mechanism for secondary glaucoma after diagnosis, other mechanisms such as angle narrowing and anterior chamber hemorrhage are not infrequent. Initial retinal detachment and intraocular pressure with tumor thickness could inform interim assessments of intraocular pressure and neovascularization. Ophthalmology Glaucoma 2023;6:29-41 2022 by the American Academy of Ophthalmology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/ 4.0/).
引用
收藏
页码:29 / 41
页数:13
相关论文
共 50 条
  • [1] Incidence and Risk Factors for Secondary Glaucoma in Eyes with Uveal Melanoma
    Stadigh, Anni E.
    Puska, Paivi M.
    Kivela, Tero T.
    OPHTHALMOLOGY, 2023, 130 (03) : 234 - 234
  • [2] Red Laser Cyclophotocoagulation in the Treatment of Secondary Glaucoma in Eyes With Uveal Melanoma
    Piirtola, Anni
    Puska, Paivi
    Kivela, Tero
    JOURNAL OF GLAUCOMA, 2014, 23 (01) : 50 - 55
  • [3] Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors
    Kim, Eun-Ah
    Salazar, Diana
    McCannel, Colin A.
    Kamrava, Mitchell
    Demanes, David J.
    Lamb, James
    Caprioli, Joseph
    McCannel, Tara A.
    JOURNAL OF GLAUCOMA, 2020, 29 (01) : 1 - 10
  • [4] Glaucoma after Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors
    Kim, Eun-Ah
    Kamrava, Mitchell
    Lamb, James
    Caprioli, Joseph
    McCannel, Tara A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [5] Secondary glaucoma as initial manifestation of uveal melanoma
    Othman, Ihab Saad
    Assem, Maher
    Zaki, Iman M. A.
    SAUDI JOURNAL OF OPHTHALMOLOGY, 2013, 27 (03) : 203 - 208
  • [6] Incidence of secondary glaucoma after treatment of uveal melanoma with robotic radiosurgery versus brachytherapy
    Siedlecki, Jakob
    Reiterer, Veronika
    Leicht, Simon
    Foerster, Paul
    Kortuem, Karsten
    Schaller, Ulrich
    Priglinger, Siegfried
    Fuerweger, Christoph
    Muacevic, Alexander
    Eibl-Lindner, Kirsten
    ACTA OPHTHALMOLOGICA, 2017, 95 (08) : e734 - e739
  • [7] Outcomes of Glaucoma Drainage Device Surgery in Eyes with Treated Uveal Melanoma
    Fatehi, Nima
    McCannel, Tara A.
    Giaconi, JoAnn
    Caprioli, Joseph
    Law, Simon K.
    Nouri-Mahdavi, Kouros
    OCULAR ONCOLOGY AND PATHOLOGY, 2019, 5 (01) : 20 - 27
  • [8] Outcomes of lensectomy and risk factors for failure in spherophakic eyes with secondary glaucoma
    Rao, Divya P.
    John, Praveen J.
    Ali, Mohammed Hasnat
    Kekunnaya, Ramesh
    Jalali, Subhadra
    Garudadri, Chandra Sekhar
    Senthil, Sirisha
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2018, 102 (06) : 790 - 795
  • [9] ANTERIOR UVEAL MELANOMA, WITH SECONDARY KERATITIS, CATARACT, AND GLAUCOMA, IN A HORSE
    DAVIDSON, HJ
    BLANCHARD, GL
    WHEELER, CA
    RENDER, JA
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1991, 199 (08) : 1049 - 1050
  • [10] Nonoccupational risk factors for uveal melanoma
    Stang, A
    Anastassiou, G
    Ahrens, W
    Bornfeld, N
    Jöckel, KH
    GESUNDHEITSWESEN, 2001, 63 (07) : 480 - 480